TuHURA Biosciences (HURA) Accumulated Expenses (2023 - 2026)

TuHURA Biosciences' Accumulated Expenses history runs 4 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 17.64% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $1.7 million, a 17.64% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 31.29% from the prior year.
• Accumulated Expenses rose to $1.7 million in Q1 2026 per HURA's latest filing, from $1.5 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.7 million in Q1 2026 and bottomed at $336000.0 in Q3 2024.
• The 4-year median for Accumulated Expenses is $1.2 million (2025), against an average of $1.2 million.
• Across the five-year window, Accumulated Expenses retreated 17.93% in 2024 and soared 261.27% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $1.4 million in 2023, then declined by 17.93% to $1.2 million in 2024, then soared by 31.29% to $1.5 million in 2025, then increased by 12.01% to $1.7 million in 2026.
• Per Business Quant, the three latest HURA Accumulated Expenses figures stand at $1.7 million (Q1 2026), $1.5 million (Q4 2025), and $1.2 million (Q3 2025).